Journal article · 2024 · Open access
Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study
Journal of Medical Internet Research, 26, e45719 · Published 8 May 2024 · DOI 10.2196/45719
In brief
“Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study” is a 2024 journal article by Yan Jia and 9 co-authors, published in Journal of Medical Internet Research. OpenAlex counts 8 citations as of 22 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Medical Internet Research.
- Citations
- 8
- Most cited in
- 2025 (5)
- Field-weighted impact
- 1.15
- References
- 64
- Authors
- 10
Abstract
BACKGROUND: International health policies and researchers have emphasized the value of evaluating patient-reported outcomes (PROs) in clinical studies. However, the characteristics of PROs in adult tumor clinical trials in China remain insufficiently elucidated. OBJECTIVE: This study aims to assess the application and characteristics of PRO instruments as primary or secondary outcomes in adult randomized clinical trials related to tumors in China. METHODS: This cross-sectional study identified tumor-focused randomized clinical trials conducted in China between January 1, 2010, and June 30, 2022. The ClinicalTrials.gov database and the Chinese Clinical Trial Registry were selected as the databases. Trials were classified into four groups based on the use of PRO instruments: (1) trials listing PRO instruments as primary outcomes, (2) trials listing PRO instruments as secondary outcomes, (3) trials listing PRO instruments as coprimary outcomes, and (4) trials without any mention of PRO instruments. Pertinent data, including study phase, settings, geographic regions, centers, participant demographics (age and sex), funding sources, intervention types, target diseases, and the names of PRO instruments, were extracted from these trials. The target diseases involved in the trials were grouped according to the American Joint Committee on Cancer Staging Manual, 8th Edition. RESULTS: Among the 6445 trials examined, 2390 (37.08%) incorporated PRO instruments as part of their outcomes. Within this subset, 26.82% (641/2390) listed PRO instruments as primary outcomes, 52.72% (1260/2390) as secondary outcomes, and 20.46% (489/2390) as coprimary outcomes. Among the 2,155,306 participants included in these trials, PRO instruments were used to collect data from 613,648 (28.47%) patients as primary or secondary outcomes and from 74,287 (3.45%) patients as coprimary outcomes. The most common conditions explicitly using specified PRO instruments included thorax tumors (217/1280, 16.95%), breast tumors (176/1280, 13.75%), and lower gastrointestinal tract tumors (173/1280, 13.52%). Frequently used PRO instruments included the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire-30, the visual analog scale, the numeric rating scale, the Traditional Chinese Medicine Symptom Scale, and the Pittsburgh Sleep Quality Index. CONCLUSIONS: Over recent years, the incorporation of PROs has demonstrated an upward trajectory in adult randomized clinical trials on tumors in China. Nonetheless, the infrequent measurement of the patient's voice remains noteworthy. Disease-specific PRO instruments should be more effectively incorporated into various tumor disease categories in clinical trials, and there is room for improvement in the inclusion of PRO instruments as clinical trial end points.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Jia, Y., Li, Q., Zhang, X. W., Yan, Y. N., Yan, S., Li, S., Li, W., Wu, X., Rong, H., & Liu, J. (2024). Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study. Journal of Medical Internet Research, 26, e45719. https://doi.org/10.2196/45719
MLA 9
Jia, Yan, et al. “Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.” Journal of Medical Internet Research, vol. 26, 2024, p. e45719. https://doi.org/10.2196/45719.
Chicago
Jia, Yan, Qi Li, Xiao Wen Zhang, Yi Nong Yan, Shiyan Yan, Shunping Li, Wei Li, Xiaowen Wu, Hongguo Rong, and Jianping Liu. 2024. “Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.” Journal of Medical Internet Research 26: e45719. https://doi.org/10.2196/45719.
Harvard
Jia, Y. et al. (2024) ‘Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study’, Journal of Medical Internet Research, 26, p. e45719. doi:10.2196/45719.
IEEE
Y. Jia et al., “Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study,” Journal of Medical Internet Research, vol. 26, p. e45719, 2024, doi: 10.2196/45719.
BibTeX
@article{jia2024application,
title = {{Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study}},
author = {Jia, Yan and Li, Qi and Zhang, Xiao Wen and Yan, Yi Nong and Yan, Shiyan and Li, Shunping and Li, Wei and Wu, Xiaowen and Rong, Hongguo and Liu, Jianping},
journal = {Journal of Medical Internet Research},
year = {2024},
volume = {26},
pages = {e45719},
doi = {10.2196/45719},
url = {https://doi.org/10.2196/45719}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- patient-reported outcomes
- adult oncology
- primary and secondary outcomes
- quality of life
- EORTC QLQ-C30
- EORTC QLQ-LC13
- EORTC QLQ-BR23
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Jia, Y., Li, Q., Zhang, X. W., Yan, Y. N., Yan, S., Li, S., Li, W., Wu, X., Rong, H., & Liu, J. (2024). Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study. Journal of Medical Internet Research, 26, e45719. https://doi.org/10.2196/45719
How many times has this paper been cited?
8 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Medical Internet Research: sign in and open the full text from this page.
Who wrote this paper?
Yan Jia, Qi Li, Xiao Wen Zhang, Yi Nong Yan, Shiyan Yan, Shunping Li, Wei Li, Xiaowen Wu, Hongguo Rong, Jianping Liu.
What is the DOI of this paper?
10.2196/45719, permanently at https://doi.org/10.2196/45719. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.